MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
COAG — Hemab Therapeutics Holdings, Inc. Common Stock
NasdaqHemab Therapeutics Holdings, Inc. Common Stock
$31.11
+0.05(+0.16%)
- O
- 31.49
- H
- 31.49
- L
- 30.06
- V
- 354.14K
⏱️ End-of-day dataAs of Oct 2, 2026
COAG — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 |
|---|---|
| Fiscal Date | 2026-03-31 |
| Period | quarterly |
| Year | 2,026.00 |
| Cash And Cash Equivalents | 49,860.00 |
| Other Short Term Investments | 113,671.00 |
| Other Receivables | 1,430.00 |
| Prepaid Assets | 4,470.00 |
| Total Current Assets | 169,431.00 |
| Properties | 887.00 |
| Machinery Furniture Equipment | 475.00 |
| Leases | 82.00 |
| Accumulated Depreciation | -796.00 |
| Other Non Current Assets | 4,240.00 |
| Total Non Current Assets | 5,827.00 |
| Total Assets | 175,258.00 |
| Accounts Payable | 5,682.00 |
| Accrued Expenses | 5,677.00 |
| Short Term Debt | 544.00 |
| Pensions | 1,286.00 |
| Total Current Liabilities | 13,189.00 |
| Long Term Debt | 519.00 |
| Total Non Current Liabilities | 360,687.00 |
| Total Liabilities | 373,876.00 |
| Common Stock | 0.00 |
| Retained Earnings | -204,545.00 |
| Other Shareholders Equity | -439.00 |
| Total Shareholders Equity | -198,618.00 |
| Additional Paid In Capital | 6,366.00 |